Table 3.
Primary healthcare presentations with scabies and skin and soft tissue infections. (*individuals may have had more than one condition at presentation; the total refers to the number of people presenting and so is less than the sum of the rows above).
| Condition | Period before mass drug administration |
Period after mass drug administration |
Comparison |
||
|---|---|---|---|---|---|
| n | Incidence per 1000 (95%CI) | n | Incidence per 1000 (95%CI) | Incidence rate ratio (95% CI) | |
| Abscess | 8052 | 63.5 (62.1––64.8) | 7709 | 59.6 (58.3–60.9) | 0.94 (0.67–0.91) |
| Scabies | 3643 | 28.7 (27.8–29.7) | 1870 | 14.5 (13.8–15.1) | 0.5 (0.48–0.53) |
| Impetigo | 2738 | 21.6 (20.8–22.4) | 1687 | 13 (12.4–13.7) | 0.6 (0.57–0.64) |
| Infected scabies | 1133 | 8.9 (8.4–9.5) | 551 | 4.3 (3.9–4.6) | 0.48 (0.43–0.53) |
| Cellulitis | 416 | 3.3 (3–3.6) | 410 | 3.2 (2.9–3.5) | 0.97 (0.84–1.11) |
| Severe skin infection | 186 | 1.5 (1.3–1.7) | 105 | 0.8 (0.7–1) | 0.55 (0.43–0.71) |
| Total* | 13736 | 108.3 (106.6–110) | 11151 | 86.2 (84.7–87.7) | 0.79 (0.78–0.82) |